These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11182136)

  • 1. Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis.
    Song C; Hiipakka RA; Liao S
    Steroids; 2001 Jun; 66(6):473-9. PubMed ID: 11182136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
    Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
    Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
    Wong J; Quinn CM; Brown AJ
    Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
    Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages.
    Rigamonti E; Helin L; Lestavel S; Mutka AL; Lepore M; Fontaine C; Bouhlel MA; Bultel S; Fruchart JC; Ikonen E; Clavey V; Staels B; Chinetti-Gbaguidi G
    Circ Res; 2005 Sep; 97(7):682-9. PubMed ID: 16141411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
    Millatt LJ; Bocher V; Fruchart JC; Staels B
    Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux.
    Wong J; Quinn CM; Brown AJ
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2365-71. PubMed ID: 15514210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
    Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
    Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
    Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
    Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
    Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport.
    Crestani M; De Fabiani E; Caruso D; Mitro N; Gilardi F; Vigil Chacon AB; Patelli R; Godio C; Galli G
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):92-6. PubMed ID: 14748721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoregulation of the human liver X receptor alpha promoter.
    Laffitte BA; Joseph SB; Walczak R; Pei L; Wilpitz DC; Collins JL; Tontonoz P
    Mol Cell Biol; 2001 Nov; 21(22):7558-68. PubMed ID: 11604492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
    Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
    Argmann CA; Sawyez CG; McNeil CJ; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):475-82. PubMed ID: 12615696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.